Protein-based nanocarriers as promising drug and gene delivery systems

Journal of Controlled Release

Volumn 161, Issue 1, 2012, Pages 38-49

  Elzoghby, Ahmed O ^a   Samy, Wael M ^b   Elgindy, Nazik A ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b BEIRUT ARAB UNIVERSITY   (Lebanon)

Author keywords

Animal proteins; Drug delivery; Gene delivery; Plant proteins; Protein nanocarriers

Indexed keywords

ANIMAL PROTEINS; COLLOIDAL DRUG CARRIERS; CROSS-LINKERS; DRUG BINDING; GENE DELIVERY; GENE DELIVERY SYSTEMS; IN-VITRO; NANOCARRIERS; PLANT PROTEINS; PROTEIN STRUCTURES; RENEWABLE SOURCES; SITE-SPECIFIC; TOXIC CHEMICALS;

DRUG DELIVERY; RECOMBINANT PROTEINS;

GENE TRANSFER;

ALPHA LACTALBUMIN; BETA LACTOGLOBULIN; BOVINE SERUM ALBUMIN; CASEIN; COLLAGEN; CYANAMIDE; ELASTIN; EPIGALLOCATECHIN GALLATE; GELATIN; GLIADIN; HUMAN SERUM ALBUMIN; MILK PROTEIN; N HYDROXYSUCCINIMIDE; NANOCARRIER; ODORRANALECTIN; OVALBUMIN; PLANT LECTIN; PROTEIN NANOCARRIER; SILK FIBROIN; SOYBEAN PROTEIN; ULEX EUROPAEUS AGGLUTININ; UNCLASSIFIED DRUG; WHEAT GERM AGGLUTININ; ZEIN;

APOPTOSIS; AREA UNDER THE CURVE; AUTOPHAGY; BINDING AFFINITY; BIOCOMPATIBILITY; COACERVATION; CROSS LINKING; DISULFIDE BOND; DRUG BINDING; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EMULSION; GELATION; GENE DELIVERY SYSTEM; HUMAN; HYDROLYSIS; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; LOW TEMPERATURE; MAXIMUM PLASMA CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; OUTCOME ASSESSMENT; PH; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; SILKWORM; SOLUBILITY; SOYBEAN; SPRAY DRYING; SUSTAINED DRUG RELEASE; TISSUE ENGINEERING;

ANIMALS; DRUG CARRIERS; GENE TRANSFER TECHNIQUES; HUMANS; NANOSTRUCTURES; PLANT PROTEINS; PLANTS; PROTEINS;

EID: 84862607937     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.04.036     Document Type: Review

References (141)

1. V.P. Torchilin, Nanotechnology in Drugs, Second Edition Imperial College Press, London, 2008.
2. S.K. Sahoo, V. Labhasetwar, Nanotech approaches to drug delivery and imaging, Drug Discovery Today 8 (2008) 1112-1120.
3. A. Kumari, S.K. Yadav, S.C. Yadav, Biodegradable polymeric nanoparticles based drug delivery systems, Colloids Surf. B Biointerfaces 75 (2010) 1-18.
4. O.C. Farokhzad, R. Langer, Impact of nanotechnology on drug delivery, ACS Nano 3 (2009) 16-20.
5. L. Chen, G.E. Remondetto, M. Subirade, Food protein-based materials as nutraceutical delivery systems, Trends Food Sci. Technol. 17 (2006) 272-283.
6. A.O. Elzoghby,W.S. Abo El-Fotoh, N.A. Elgindy, Casein-based formulations as promising controlled release drug delivery systems, J. Control. Release 153 (2011) 206-216.
7. A.O. Elzoghby, W.M. Samy, N.A. Elgindy, Albumin-based nanoparticles as potential controlled release drug delivery systems, J. Control. Release 167 (2012) 168-182.
8. E. Leo, M.A. Vandelli, R. Cameroni, F. Forni, Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: involvement of the drug in the cross-linking process, Int. J. Pharm. 155 (1997) 75-82. (Pubitemid 27368124)
9. A. Veis, The Macromolecular Chemistry of Gelatin, Academic Press, New York, 1964.
10. K. Zwiorek, J. Kloeckner, E. Wagner, C. Coester, Gelatin nanoparticles as a new and simple gene delivery system, J. Pharm. Pharm. Sci. 7 (2005) 22-28.
11. W. Fraunhofer, G. Winter, C. Coester, Asymmetrical flow field-flow fractionation and multi-angle light scattering for analysis of gelatin nanoparticle drug carrier systems, Anal. Chem. 76 (2004) 1909-1920. (Pubitemid 38451507)
12. T.K. Yeh, Z. Lu, M.G. Wientjes, J.L.-S. Au, Formulating paclitaxel in nanoparticles alters its disposition, Pharm. Res. 22 (2005) 867-874. (Pubitemid 40898096)
13. S.K. Jain, Y. Gupta, A. Jain, A.R. Saxena, P. Khare, A. Jain, Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery, Nanomedicine 4 (2008) 41-48. (Pubitemid 351324205)
14. A.K. Bajpai, J. Choubey, Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate, J. Mater. Sci. Mater. Med. 17 (2006) 345-358.
15. M. Nahar, D. Mishra, V. Dubey, N.K. Jain, Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles, Nanomedicine 4 (2008) 252-261.
16. E.J. Lee, S.A. Khan, J.K. Park, K.-H. Lim, Studies on the characteristics of drug-loaded gelatin nanoparticles prepared by nanoprecipitation, Bioprocess Biosyst. Eng. 35 (2011) 297-307.
17. N.T. Qazvini, S. Zinatloo, Synthesis and characterization of gelatin nanoparticles using CDI/NHS as a non-toxic cross-linking system, J.Mater. Sci.Mater.Med. 22 (2011) 63-69.
18. R. Kumar, R.C. Nagarwal, M. Dhanawat, J.K. Pandit, In vitro and in vivo study of indomethacin-loaded gelatin nanoparticles, J. Biomed. Nanotechnol. 7 (2011) 325-333.
19. V. Singh, A.K. Chaudhary, Development and characterization of rosiglitazone loaded gelatin nanoparticles using two step desolvation method, Int. J. Pharm. Sci. Rev. Res. 5 (2010) 100-103.
20. Y.-Z. Zhao, X. Li, C.-T. Lu, Y.-Y. Xu, H.-F. Lv, D.-D. Dai, L. Zhang, C.-Z. Sun, W. Yang, X.-K. Li, Y.-P. Zhao, H.-X. Fu, L. Cai, M. Lin, L.-J. Chen, M. Zhang, Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy, Acta Diabetol. In Press (2011).
21. J. Vandervoort, A. Ludwig, Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use pilocarpine hydrocortisone, Eur. J. Pharm. Biopharm. 57 (2004) 251-261. (Pubitemid 38283701)
22. A. Saxena, K. Sachin, H.B. Bohidar, A.K. Verma, Effect of molecular weight heterogeneity on drug encapsulation efficiency of gelatin nanoparticles, Colloids Surf. B Biointerfaces 45 (2005) 42-48. (Pubitemid 41207658)
23. Y. Uesugi, H. Kawata, J. Jo, Y. Saito, Y. Tabata, An ultrasound- responsive nano delivery system of tissue-type plasminogen activator for thrombolytic therapy, J. Control. Release 147 (2010) 269-277.
24. J.C. Zillies, K. Zwiorek, F. Hoffmann, A. Vollmar, T.J. Anchordoquy, G. Winter, C. Coester, Formulation development of freeze-dried oligonucleotide- loaded gelatin nanoparticles, Eur. J. Pharm. Biopharm. 70 (2008) 514-521.
25. C.J. Coester, K. Langer, H. Van Briesen, J. Kreuter, Gelatin nanoparticles by two-step desolvation-a new preparation method, surface modifications and cell uptake, J. Microencapsul. 17 (2000) 187-193. (Pubitemid 30135796)
26. A.K. Gupta, M. Gupta, S.J. Yarwood, A.S.G. Curtisa, Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology and cytoskeleton organization of human fibroblasts, J. Control. Release 95 (2004) 197-207. (Pubitemid 38230035)
27. H.C. Liang, W.H. Chang, K.J. Lin, H.W. Sung, Genipin-crosslinked gelatin microspheres as a drug carrier for intramuscular administration: in vitro and in vivo studies, J. Biomed. Mater. Res. 65A (2003) 271-282.
28. Y.-W. Won, Y.-H. Kim, Recombinant human gelatin nanoparticles as a protein drug carrier, J. Control. Release 127 (2008) 154-161.
29. S. Fuchs, M. Kutscher, T. Hertel, G.Winter, M. Pietzsch, C. Coester, Transglutaminase: new insights into gelatin nanoparticle cross-linking, J. Microencapsul. 27 (2010) 747-754.
30. M.J. Hou, M. Kim, D.O. Shah, A light scattering study on the droplet size and interdroplet interaction in microemulsion of AOT-oil water systems, J. Colloid Interface Sci. 123 (1998) 398-412.
31. M.D. Bhavsar, M.M. Amiji, Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS), J. Control. Release 119 (2007) 339-348. (Pubitemid 46770879)
32. C. Kriegel, M. Amiji, Oral TNF-α gene silencing using a polymeric microspherebased delivery system for the treatment of inflammatory bowel disease, J. Control. Release 150 (2011) 77-86.
33. G.K. Zorzi, J.E. Párraga, B. Seijo, A. Sánchez, Hybrid nanoparticle design based on cationized gelatin and the polyanions dextran sulfate and chondroitin sulfate for ocular gene therapy, Macromol. Biosci. 11 (2011) 905-913.
34. D. Ding, Z. Zhu, Q. Liu, J. Wang, Y. Hu, X. Jiang, B. Liu, Cisplatin-loaded gelatinpoly (acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors, Eur. J. Pharm. Biopharm. 79 (2011) 142-149.
35. F.-M. Chen, Z.-W. Ma, G.-Y. Dong, Z.-F. Wu, Composite glycidyl methacrylated dextran (Dex-GMA)/gelatin nanoparticles for localized protein delivery, Acta Pharmacol. Sin. 30 (2009) 485-493.
36. A. Jain, A. Gulbake, A. Jain, S. Shilpi, P. Hurkat, A. Jain, S.K. Jain, Development of surface-functionalised nanoparticles for FGF2 receptor-based solid tumour targeting, J. Microencapsul. 29 (2012) 95-102.
37. C.H. Lee, A. Singla, Y. Lee, Biomedical applications of collagen, Int. J. Pharm. 221 (2001) 1-22. (Pubitemid 32524031)
38. W. Friess, Collagen-biomaterial for drug delivery, Eur. J. Pharm. Biopharm. 45 (1998) 113-136.
39. J.J. Marty, R.C. Openheim, P. Speiser, Nanoparticles a new colloidal drug delivery system, Pharm. Acta Helv. 53 (1978) 17-23.
40. A. Bender, H. von Briesen, J. Kreuter, I.B. Duncan, H. Rubsamen-Waigmann, Efficiency of nanoparticles as a carrier system for antiviral agents in human monocytes/ macrophages in vitro, Antimicrob. Agents Chemother. 40 (1996) 1467-1471. (Pubitemid 26169056)
41. M.S. El-Samaligy, P. Rohdewald, Reconstituted collagen nanoparticles, a novel drug carrier delivery system, J. Pharm. Pharmacol. 35 (1983) 537-539. (Pubitemid 13075893)
42. M. Nicklas, W. Schatton, S. Heinemann, T. Hanke, J. Kreuter, Preparation and characterization of marine sponge collagen nanoparticles and employment for the transdermal delivery of 17β-estradiol-hemihydrate, Drug Dev. Ind. Pharm. 35 (2009) 1035-1042.
43. X. Niu, Q. Feng, M. Wang, X. Guo, Q. Zheng, Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2, J. Control. Release 134 (2009) 111-117.
44. F. Kratz, Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles, J. Control. Release 132 (2008) 171-183.
45. B. Elsadek, F. Kratz, Impact of albumin on drug delivery-new applications on the horizon, J. Control. Release, In press (2011).
46. K. Park, Albumin: A versatile carrier for drug delivery, J. Control. Release, In press (2011).
47. M. Dadparvar, S. Wagner, S. Wien, J. Kufleitner, F. Worek, H. von Briesen, J. Kreuter, HI 6 human serum albumin nanoparticles-development and transport over an in vitro blood-brain barrier model, Toxicol. Lett. 206 (2011) 60-66.
48. A. Arnedo, J.M. Irache, M. Merodio, M.S.E. Millán, Albumin nanoparticles improved the stability, nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotide, J. Control. Release 94 (2004) 217-227. (Pubitemid 37542391)
49. 188Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles in vivo, Int. J. Nanomedicine 6 (2011) 3077-3085.
50. J. Weyermann, D. Lochmann, C. Georgens, A. Zimmer, Albumin-protamine- oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect, Eur. J. Pharm. Biopharm. 59 (2005) 431-438. (Pubitemid 40342517)
51. J. Li, P. Yao, Self-assembly of ibuprofen and bovine serum albumin-dextran conjugates leading to effective loading of the drug, Langmuir 25 (2009) 6385-6391.
52. Y.D. Livney, Milk proteins as vehicles for bioactives, Curr. Opin. Colloid Interface Sci. 15 (2010) 73-83.
53. D.S. Horne, Casein micelle structure: models and muddles, Curr. Opin. Colloid Interface Sci. 11 (2006) 148-153. (Pubitemid 43867391)
54. P. Zimet, D. Rosenberg, Y.D. Livney, Re-assembled casein micelles and casein nanoparticles as nano-vehicles for ω-3 polyunsaturated fatty acids, Food Hydrocolloids 25 (2011) 1270-1276.
55. A. Shapira, G. Markman, Y.G. Assaraf, Y.D. Livney, β-casein-based nanovehicles for oral delivery of chemotherapeutic drugs: drug-protein interactions and mitoxantrone loading capacity, Nanomedicine 6 (2010) 547-555.
56. A. Shapira, Y.G. Assaraf, D. Epstein, Y.D. Livney, Beta-casein nanoparticles as an oral delivery system for chemotherapeutic drugs: impact of drug structure and properties on co-assembly, Pharm. Res. 27 (2010) 2175-2186.
57. A. Shapira, I. Davidson, N. Avni, Y.G. Assaraf, Y.D. Livney, β-Casein nanoparticle-based oral drug delivery system for potential treatment of gastric carcinoma: stability, target-activated release and cytotoxicity, Eur. J. Pharm. Biopharm. In press (2011).
58. M. Bachar, A. Mandelbaum, I. Portnaya, H. Perlstein, S. Even-Chen, Y. Barenholz, D. Danino, Development and characterization of a novel drug nanocarrier for oral delivery, based on self-assembled β-casein micelles, J. Control. Release, In press (2012).
59. M. Esmaili, S.M. Ghaffari, Z. Moosavi-Movahedi, M.S. Atri, A. Sharifizadeh, M. Farhadi, R. Yousefi, J.-M. Chobert, T. Haertlé, A.A. Moosavi-Movahedi, Beta casein-micelle as a nano vehicle for solubility enhancement of curcumin; food industry application, LWT-Food Sci. Technol. 44 (2011) 2166-2172.
60. S. Ko, S. Gunasekaran, Preparation of sub-100-nm β-lactoglobulin (βLG) nanoparticles, J. Microencapsul. 23 (2006) 887-898.
61. S. Gunasekaran, L. Xiao, M.M. Ould Eleya, Whey protein concentrate hydrogels as bioactive carriers, J. Appl. Polym. Sci. 99 (2006) 2470-2476.
62. S. Gunasekaran, S. Ko, L. Xiao, Use of whey proteins for encapsulation and controlled delivery applications, J. Food Eng. 83 (2007) 31-40. (Pubitemid 46802869)
63. A. Shpigelman, G. Israeli, Y.D. Livney, Thermally-induced protein polyphenol co-assemblies: beta lactoglobulin-based nanocomplexes as protective nanovehicles for EGCG, Food Hydrocolloids 24 (2010) 735-743.
64. A.H. Sneharani, J.V. Karakkat, S.A. Singh, A.G. Rao, Interaction of curcumin with β-Lactoglobulin-stability, spectroscopic analysis, and molecular modeling of the complex, J. Agric. Food Chem. In press (2010).
65. H.J. Giroux, J. Houde, M. Britten, Preparation of nanoparticles from denatured whey protein by pH-cycling treatment, Food Hydrocolloids 24 (2010) 341-346.
66. W. Zhang, Q. Zhong, Microemulsions as nanoreactors to produce whey protein nanoparticles with enhanced heat stability by thermal pretreatment, Food Chem. 119 (2010) 1318-1325.
67. M. Girard, S.L. Turgeon, S.F. Gauthier, Interbiopolymer complexing between β-lactoglobulin and low- and high-methoxylated pectin measured by potentiometric titration and ultrafiltration, Food Hydrocolloids 16 (2002) 585-591. (Pubitemid 35177847)
68. L.Y. Zhang, A. Dudhani, L. Lundin, S.L. Kosaraju, Macromolecular conjugate based particulates: preparation, characterization and evaluation of controlled release properties, Eur. Polym. J. 45 (2009) 1960-1969.
69. K. Numata, D.L. Kaplan, Silk-based delivery systems of bioactive molecules, Adv. Drug Deliv. Rev. 62 (2010) 1497-1508.
70. G.H. Altman, F. Diaz, C. Jakuba, T. Calabro, R.L. Horan, J. Chen, H. Lu, J. Richmond, D.L. Kaplan, Silk-based biomaterials, Biomaterials 24 (2003) 401-416. (Pubitemid 35291198)
71. H.-B. Yan, Y.-Q. Zhang, Y.-L. Ma, L.-X. Zhou, Biosynthesis of insulin-silk fibroin nanoparticles conjugates and in vitro evaluation of a drug delivery system, J. Nanopart. Res. 11 (2009) 1937-1946.
72. A.S. Lammel, X. Hu, S.-H. Park, D.L. Kaplan, T.R. Scheibel, Controlling silk fibroin particle features for drug delivery, Biomaterials 31 (2010) 4583-4591.
73. J. Kundu, Y.-I. Chung, Y.H. Kim, G. Tae, S.C. Kundu, Silk fibroin nanoparticles for cellular uptake and control release, Int. J. Pharm. 388 (2010) 242-250.
74. X. Wang, T. Yucel, Q. Lu, X. Hu, D.L. Kaplan, Silk nanospheres and microspheres from silk/pva blend films for drug delivery, Biomaterials 31 (2010) 1025-1035.
75. V. Gupta, A. Aseh, C.N. Ríos, B.B. Aggarwal, A.B. Mathur, Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy, Int. J. Nanomedicine 4 (2009) 115-122.
76. B.B. Mandal, S.C. Kundu, Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery, Nanotechnology 20 (2009) 355101.
77. E.R. Wright, V.P. Conticello, Self-assembly of block copolymers derived from elastin-mimetic polypeptide sequences, Adv. Drug Deliv. Rev. 54 (2002) 1057-1073.
78. M. Miao, J.T. Cirulis, S. Lee, F.W. Keeley, Structural determinants of cross-linking and hydrophobic domains for self-assembly of elastin-like polypeptides, Biochemistry 44 (2005) 14367-14375. (Pubitemid 41533060)
79. J.C. Rodríguez-Cabello, S. Prieto, J. Reguera, F.J. Arias, A. Ribeiro, Biofunctional design of elastin-like polymers for advanced applications in nanobiotechnology, J. Biomater. Sci. Polym. Ed. 18 (2007) 269-286. (Pubitemid 46403136)
80. J.R. McDaniel, D.J. Callahan, A. Chilkoti, Drug delivery to solid tumors by elastin-like polypeptides, Adv. Drug Deliv. Rev. 62 (2010) 1456-1467.
81. W.E. Liu, M.R. Dreher, D.Y. Furgeson, K.V. Peixoto, H. Yuan, M.R. Zalutsky, A. Chilkoti, Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice, J. Control. Release 116 (2006) 170-178. (Pubitemid 44854277)
82. K. Trabbic-Carlson, L. Liu, B. Kim, A. Chilkoti, Expression and purification of recombinant proteins from Escherichia coli: comparison of an elastin-like polypeptide fusion with an oligohistidine fusion, Protein Sci. 13 (2004) 3274-3284. (Pubitemid 39557797)
83. M.F. Shamji, H. Betre, V.B. Kraus, J. Chen, A. Chilkoti, R. Pichika, K. Masuda, L.A. Setton, Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic, Arthritis Rheum. 56 (2007) 3650-3661. (Pubitemid 350100699)
84. R. Herrero-Vanrell, A.C. Rincün, M. Alonso, V. Reboto, I.T. Molina-Martinez, J.C. Rodríguez-Cabello, Self-assembled particles of an elastin-like polymer as vehicles for controlled drug release, J. Control. Release 102 (2005) 113-122. (Pubitemid 40093779)
85. P.C. Bessa, R. Machado, S. Nürnberger, D. Dopler, A. Banerjee, A.M. Cunha, J.C. Rodríguez-Cabello, H. Redl, M. van Griensven, R.L. Reis, M. Casal, Thermoresponsive self-assembled elastin-based nanoparticles for delivery of BMPs, J. Control. Release 142 (2010) 312-318.
86. 251, by gamma-ray crosslinking, Polym. Bull. 64 (2010) 707-716.
87. A. Hatefi, J. Cappello, H. Ghandehari, Adenoviral gene delivery to solid tumors by recombinant silk-elastinlike protein polymers, Pharm. Res. 24 (2007) 773-779. (Pubitemid 46411966)
88. Y. Chen, P. Youn, D.Y. Furgeson, Thermo-targeted drug delivery of geldanamycin to hyperthermic tumor margins with diblock elastin-based biopolymers, J. Control. Release 155 (2011) 175-183.
89. T.H. Chen, Y. Bae, D.Y. Furgeson, Intelligent biosynthetic nanobiomaterials (IBNs) for hyperthermic gene delivery, Pharm. Res. 25 (2008) 683-691. (Pubitemid 351357719)
90. D.Y. Furgeson, M.R. Dreher, A. Chilkoti, Structural optimization of a "smart"doxorubicin-polypeptide conjugate for thermally targeted delivery to solid tumors, J. Control. Release 110 (2006) 362-369. (Pubitemid 41827490)
91. U.M. Krishna, A.W. Martinez, J.M. Caves, E.L. Chaikof, Hydrazone self-crosslinking of multiphase elastin-like block copolymer networks, Acta Biomater. 8 (2012) 988-997.
92. R.E. Sallach, W. Cui, J. Wen, A. Martinez, V.P. Conticello, E.L. Chaikof, Elastin mimetic protein polymers capable of physical and chemical crosslinking, Biomaterials 30 (2009) 409-422.
93. J.A. MacKay, M. Chen, J.R. McDaniel, W. Liu, A.J. Simnick, A. Chilkoti, Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection, Nat. Mater. 8 (2009) 993-999.
94. I. Ezpeleta, J.M. Irache, S. Stainmesse, C. Chabenat, J. Gueguen, Y. Popineau, A.M. Orecchioni, Gliadin nanoparticles for the controlled release of all-transretinoic acid, Int. J. Pharm. 131 (1996) 191-200.
95. L.F. Lai, H.X. Guo, Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting, Int. J. Pharm. 404 (2011) 317-323.
96. Q. Zhong, M. Jin, Zein nanoparticles produced by liquid-liquid dispersion, Food Hydrocolloids 23 (2009) 2380-2387.
97. Q. Zhong, H. Tian, S. Zivanovic, Encapsulation of fish oil in solid zein particles by liquid-liquid dispersion, J. Food Process. Preserv. 33 (2009) 255-270.
98. J. Dong, Q.S. Sun, J.Y. Wang, Basic study of corn protein, zein, as a biomaterial in tissue engineering, surface morphology and biocompatibility, Biomaterials 25 (2004) 4691-4697. (Pubitemid 38561156)
99. X. Liu, Q. Sun, H. Wang, L. Zhang, J.-Y. Wang, Microspheres of corn protein, zein, for an ivermectin drug delivery system, Biomaterials 26 (2005) 109-115. (Pubitemid 38759476)
100. H.-J. Wang, Z.-X. Lin, X.-M. Liu, S.-Y. Sheng, J.-Y. Wang, Heparin-loaded zein microsphere film and hemocompatibility, J. Control. Release 105 (2005) 120-131. (Pubitemid 40805480)
101. N. Parris, P.H. Cooke, K.B. Hicks, Encapsulation of essential oils in zein nanospherical particles, J. Agric. Food Chem. 53 (2005) 4788-4792. (Pubitemid 40937599)
102. O.P. Perumal, S.K. Podaralla, T.M. Seefeldt, Doxorubicin loaded zein nanoparticles, AAPS Annual Meeting and Exposition, 2009.
103. S. Torres-Giner, A. Martinez-Abad, M.J. Ocio, J.M. Lagaron, Stabilization of a nutraceutical omega-3 fatty acid by encapsulation in ultrathin electrosprayed zein prolamine, J. Food Sci. 75 (2010) N69-N79.
104. Y.C. Luo, B.C. Zhang, W.H. Cheng, Q. Wang, Preparation, characterization and evaluation of selenite-loaded chitosan/TPP nanoparticles with or without zein coating, Carbohydr. Polym. 82 (2010) 942-951.
105. Y. Luo, B. Zhang, M. Whent, L. Yu, Q. Wang, Preparation and characterization of zein/chitosan complex for encapsulation of α-tocopherol, and its in vitro controlled release study, Colloids Surf. B Biointerfaces 85 (2011) 145-152.
106. 3, J. Agric. Food Chem. In Press (2011).
107. A. Teglia, G. Secchi, New protein ingredients for skin detergency: native wheat protein-surfactant complexes, Int. J. Cosmet. Sci. 16 (1994) 235-246.
108. C. Duclairoir, A.M. Orecchioni, P. Depraetere, F. Osterstock, E. Nakache, Evaluation of gliadins nanoparticles as drug delivery systems: a study of three different drugs, Int. J. Pharm. 253 (2003) 133-144. (Pubitemid 36197837)
109. M.A. Arangoa, G. Ponchel, A.M. Orecchioni, M.J. Renedo, D. Duchêne, J.M. Irache, Bioadhesive potential of gliadin nanoparticulate systems, Eur. J. Pharm. Sci. 11 (2000) 333-341.
110. M.A. Arangoa, M.A. Campanero, M.J. Renedo, G. Ponchel, J.M. Irache, Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics, Pharm. Res. 18 (2001) 1521-1527. (Pubitemid 33022406)
111. R.B. Umamaheshwari, S. Ramteke, N.K. Jain, Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model, AAPS PharmSciTech 5 (2004) e32.
112. S. Ramteke, N. Ganesh, S. Bhattacharya, N.K. Jain, Triple therapy-based targeted nanoparticles for the treatment of Helicobacter pylori, J. Drug Target. 16 (2008) 694-705.
113. S. Petruccelli, M.C. Anon, Soy protein isolate components and their interactions, J. Agric. Food Chem. 43 (1995) 1762-1767.
114. A.-C. Vega-Lugo, L.-T. Lim, Controlled release of allyl isothiocyanate using soy protein and poly(lactic acid) electrospun fibers, Food Res. Int. 42 (2009) 933-940.
115. C.-H. Tang, H. Wu, Z. Chen, X.-Q. Yang, Formation and properties of glycinin-rich and β-conglycinin-rich soy protein isolate gels induced by microbial transglutaminase, Food Res. Int. 39 (2006) 87-97. (Pubitemid 41455495)
116. J.M. Irache, L. Bergougnoux, I. Ezpeleta, J. Gueguen, A.M. Orecchioni, Optimization and in vitro stability of legumin nanoparticles obtained by a coacervation method, Int. J. Pharm. 126 (1995) 103-109. (Pubitemid 26015629)
117. C.M. Lehr, Lectin-mediated drug delivery: the second generation of bioadhesives, J. Control. Release 65 (2000) 19-29.
118. C. Bies, C.-M. Lehr, J.F. Woodley, Lectin-mediated drug targeting: history and applications, Adv. Drug Deliv. Rev. 56 (2004) 425-435. (Pubitemid 38210415)
119. C.D. Pellegrina, C. Rizzi, S. Mosconi, G. Zoccatelli, A. Peruffo, R. Chignola, Plant lectins as carriers for oral drugs: is wheat germ agglutinin a suitable candidate? Toxicol. Appl. Pharmacol. 207 (2005) 170-178. (Pubitemid 41133503)
120. Z. Wen, Z. Yan, K. Hu, Z. Pang, X. Cheng, L.R. Guo, Q. Zhang, X. Jiang, L. Fang, R. Lai, Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration, J. Control. Release 151 (2011) 131-138.
121. X. Gao, T. Wang, B. Wua, J. Chen, J. Chen, Y. Yue, N. Dai, H. Chen, X. Jiang, Quantum dots for tracking cellular transport of lectin-functionalized nanoparticles, Biochem. Biophys. Res. Commun. 377 (2008) 35-40.
122. S.-L. Liu, Z.-L. Zhang, E.-Z. Sun, J. Peng, M. Xie, Z.-Q. Tian, Y. Lin, D.-W. Pang, Visualizing the endocytic and exocytic processes of wheat germ agglutinin by quantum dot-based single-particle tracking, Biomaterials 32 (2011) 7616-7624.
123. G.J. Russell-Jones, H. Veitch, L. Arthur, Lectin-mediated transport of nanoparticles across Caco-2 and OK cells, Int. J. Pharm. 190 (1999) 165-174. (Pubitemid 29509910)
124. F. Gabor, E. Bogner, A. Weissenboeck, M. Wirth, The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery, Adv. Drug Deliv. Rev. 56 (2004) 459-480. (Pubitemid 38210417)
125. I. Ezpeleta, J.M. Irache, S. Stainmesse, C. Chabenat, J. Gueguen, A.M. Orecchioni, Preparation of lectin-vicilin nanoparticle conjugates using the carbodiimide coupling technique, Int. J. Pharm. 142 (1996) 227-233. (Pubitemid 26354648)
126. I. Ezpeleta, M.A. Arangoa, J.M. Irache, S. Stainmesse, C. Chabenat, Y. Popineau, A.M. Orecchioni, Preparation of Ulex europaeus lectin-gliadin nanoparticle conjugates and their interaction with gastrointestinal mucus, Int. J. Pharm. 191 (1999) 25-32. (Pubitemid 29502174)
127. R.B. Umamaheshwari, N.K. Jain, Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori, J. Drug Target. 11 (2003) 415-423.
128. C. Wang, P.C. Ho, L.Y. Lim, Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells, Int. J. Pharm. 400 (2010) 201-210.
129. Y.S. Yin, D.W. Chen, M.X. Qiao, X.Y. Wei, H.Y. Hu, Lectin-conjugated PLGA nanoparticles loaded with thymopentin: ex vivo bioadhesion and in vivo biodistribution, J. Control. Release 123 (2007) 27-38.
130. P.N. Gupta, S. Mahor, A. Rawat, K. Khatri, A. Goyal, S.P. Vyas, Lectin anchored stabilized biodegradable nanoparticles for oral immunization 1. Development and in vitro evaluation, Int. J. Pharm. 318 (2006) 163-173. (Pubitemid 43963301)
131. X. Gao, J. Chen, W. Tao, J. Zhu, Q. Zhang, H. Chen, X. Jiang, UEA I-bearing nanoparticles for brain delivery following intranasal administration, Int. J. Pharm. 340 (2007) 207-215. (Pubitemid 47043363)
132. X. Gao, B. Wu, Q. Zhang, J. Chen, J. Zhu, W. Zhang, Z. Rong, H. Chen, X. Jiang, Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration, J. Control. Release 121 (2007) 156-167. (Pubitemid 47212537)
133. Q. Liu, X. Shao, J. Chen, Y. Shen, C. Feng, X. Gao, Y. Zhao, J. Li, Q. Zhang, X. Jiang, In vivo toxicity and immunogenicity of wheat germ agglutinin conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal delivery to the brain, Toxicol. Appl. Pharmacol. 251 (2011) 79-84.
134. N. Zhang, Q. Ping, G. Huang, W. Xu, Y. Cheng, X. Han, Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin, Int. J. Pharm. 327 (2006) 153-159. (Pubitemid 44667334)
135. Y. Liu, P. Wang, C. Sun, N. Feng, W. Zhou, Y. Yang, R. Tan, Z. Chen, S. Wu, J. Zhao, Wheat germ agglutinin-grafted lipid nanoparticles: preparation and in vitro evaluation of the association with Caco-2 monolayers, Int. J. Pharm. 397 (2010) 155-163.
136. Y. Liu, P. Wang, C. Sun, J. Zhao, Y. Du, F. Shi, N. Feng, Bioadhesion and enhanced bioavailability by wheat germ agglutinin-grafted lipid nanoparticles for oral delivery of poorly water-soluble drug bufalin, Int. J. Pharm. 419 (2011) 260-265.
137. P.B. Malafaya, G.A. Silva, R.L. Reis, Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications, Adv. Drug Deliv. Rev. 59 (2007) 207-233. (Pubitemid 46879967)
138. K. Langer, M.G. Anhorn, I. Steinhauser, S. Dreis, D. Celebi, N. Schrickel, S. Faust, V. Vogel, Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation, Int. J. Pharm. 347 (2008) 109-117. (Pubitemid 350180317)
139. Y.W. Won, S.M. Yoon, C.H. Sonn, K.M. Lee, Y.H. Kim, Nano self-assembly of recombinant human gelatin conjugated with α-tocopheryl succinate for Hsp90 inhibitor, 17-AAG, delivery, ACS Nano 5 (2011) 3839-3848.
140. V. Chiono, E. Pulieri, G. Vozzi, G. Ciardelli, A. Ahluwalia, P. Giusti, Genipin-crosslinked chitosan/gelatin blends for biomedical applications, J. Mater. Sci. Mater. Med. 19 (2008) 889-898. (Pubitemid 351244035)
141. A.O. Elzoghby, Development and evaluation of protein nano-carriers as promising drug delivery systems. PhD thesis. University of Alexandria, Egypt (2011).